SynthesisDiagnostic pathology2014

Gemcitabine fixed-dose rate infusion for the treatment of pancreatic carcinoma: a meta-analysis of randomized controlled trials.

Jiqing Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.